Question 1

Does a low TSH mean I have Graves' disease?

Accepted Answer

No — and this is the single most useful thing to take from this page. A suppressed TSH tells you that there is too much thyroid hormone around. It does not tell you where the hormone came from, and the answer changes the treatment completely. Graves' disease is the commonest cause, and antibodies against the TSH receptor (TRAb or TSI) are the direct test for it. But the same low TSH appears in a toxic nodule or multinodular goitre, in thyroiditis — where an inflamed thyroid is leaking hormone it already made — in amiodarone-related thyroid disease, and in someone taking too much thyroid hormone. Thyroiditis is the one that matters most for getting this wrong: it is self-limiting, it typically burns out over weeks to months, and antithyroid drugs do not work for it because there is nothing being overproduced to block. Telling these apart is what antibody testing and an uptake scan are for. A low TSH is the beginning of the diagnosis, not the end of it.

Question 2

Will iodine or kelp supplements help an overactive thyroid?

Accepted Answer

No, and they can make it worse — this is one of the clearest cases where an intuitive supplement points the wrong way. Iodine is the raw material the thyroid uses to build thyroid hormone. Giving more of it to a gland that is already producing too much is the opposite of the intervention you want, and in a nodular thyroid in particular an iodine load can trigger or worsen hyperthyroidism. The confusion is understandable: iodine deficiency causes goitre and hypothyroidism, so iodine is widely marketed as being 'for the thyroid' as though the thyroid had one direction to go in. It does not. There is a narrow, specific medical use of iodine in hyperthyroidism — as a short-term treatment before surgery, or in thyroid storm, given deliberately and under supervision — but that is a hospital intervention with precise timing, not an argument for a supplement. If your thyroid is overactive, iodine and kelp are not a treatment.

Question 3

Which treatment should I choose — drugs, radioactive iodine, or surgery?

Accepted Answer

All three work, and the honest answer is that this is a genuine choice with trade-offs rather than a ranking. Antithyroid drugs (methimazole or carbimazole) avoid surgery and radiation and offer a real chance of lasting remission after a course of treatment — but a substantial proportion of people relapse afterwards, and the drugs carry the specific risks below. Radioactive iodine is definitive and straightforward, but it usually leaves you hypothyroid for life and therefore on levothyroxine — which is a trade, not a failure, since a well-treated underactive thyroid is easier to manage than an overactive one. Surgery is definitive and fast, and is preferred if the goitre is large, a nodule is suspicious, or control is needed quickly, at the cost of an operation and its specific risks. Two things genuinely tilt the decision: active Graves' eye disease, which radioactive iodine can worsen, and pregnancy or planned pregnancy, which changes everything about the timing and the choice. This is a decision to make with an endocrinologist who knows your antibody levels, your gland, your eyes and your plans.

Question 4

Is radioactive iodine safe — does it cause cancer?

Accepted Answer

This is contested, and BioSignal will not resolve it in either direction. Radioactive iodine has been used for over seventy years and its short-term safety is well established; the expected outcome is hypothyroidism, not harm. The debate concerns long-term cancer risk. A large 2019 analysis of nearly 19,000 patients from a long-running US cohort reported modest dose-related associations with solid cancer mortality — roughly a 6% relative increase in solid cancer death per 100 mGy of radiation dose to the stomach, and a similar signal for breast cancer. That finding was widely and seriously disputed: the study is observational, the dose estimates were reconstructed rather than measured, the absolute effect is small, and specialists argued the methods could not separate the treatment's effect from the underlying disease and its risk factors. Professional practice did not change on the strength of it. So the honest position is: a modest possible association, reported in one influential observational analysis, contested on methodological grounds, and not established as causal. If you are weighing radioactive iodine, this uncertainty is real and worth discussing with your endocrinologist — it is not a reason on its own to refuse an effective treatment, and it is not something to be told does not exist.

Question 5

What are the dangerous side effects of antithyroid drugs?

Accepted Answer

Two, and both are rare and both are worth knowing precisely because they are actionable. The first is agranulocytosis — a sudden collapse in the white cells that fight infection. In a Japanese cohort of over 50,000 people with Graves' disease, around 0.1% developed agranulocytosis or pancytopenia. The practical rule is what matters: if you develop a fever or a sore throat while taking methimazole, carbimazole or propylthiouracil, treat it as urgent, stop the drug, and get a white cell count the same day — a sore throat is the classic presentation, and it is the one symptom that must never be waited out. Worth knowing too: although most cases appear within the first three months, in that cohort onset ranged out to over 200 days, so the risk is not confined to the start. The second is liver injury, which is more strongly associated with propylthiouracil and can be severe; jaundice, dark urine, pale stools, itching, or right-sided abdominal pain need prompt assessment. Ordinary side effects — rash, itch, joint aches, upset stomach — are much more common and much less serious. None of this means the drugs are dangerous to take; it means they come with two specific alarms, and knowing them is what makes them safe.

Question 6

I'm pregnant, or planning to be — does that change things?

Accepted Answer

It changes almost everything, and this is the part of the page most in need of a real clinician rather than a page. The headline rule most people have heard — propylthiouracil in the first trimester, methimazole afterwards — is real and reflects guidelines, because methimazole is associated with a distinctive and more severe pattern of birth defects. But the honest evidence is more uncomfortable than that rule suggests. In a Danish nationwide study, birth defects were more common with both drugs than in unexposed pregnancies (methimazole/carbimazole 9.1%, propylthiouracil 8.0%, versus 5.4-5.7% unexposed), and switching between the two in early pregnancy was itself associated with increased risk (odds ratio 1.82). So propylthiouracil is not a safe option and methimazole a dangerous one; both carry risk, they differ in the pattern and severity of what they cause, and the switching strategy is not free either. Meanwhile untreated hyperthyroidism in pregnancy is itself harmful. Radioactive iodine is contraindicated. What this adds up to is not a decision to make from a page: if you have hyperthyroidism and are pregnant or planning to be, this needs specialist input before conception where possible, not after.

Question 7

Why are my eyes affected, and will treatment help them?

Accepted Answer

Graves' eye disease is a separate problem from the overactive thyroid, driven by the same autoimmunity attacking the tissues behind the eye — which is why it has its own treatment track and does not simply resolve when the thyroid numbers normalise. It causes grittiness, redness, swelling, bulging, and in more active disease pain on eye movement, double vision, and rarely a threat to sight. Two things are genuinely actionable. Smoking is the strongest modifiable risk factor for developing it and for it getting worse, and stopping matters more here than almost anywhere else in thyroid medicine. And the choice of thyroid treatment interacts with the eyes: radioactive iodine can worsen active eye disease, particularly in smokers, which is a specific reason it may not be the right option for you and a reason to say so before choosing. Treatment for the eyes themselves has moved considerably — from selenium in mild disease, through intravenous steroids, to targeted biologic therapy for active moderate-to-severe disease. Any change in vision, colour vision, or new double vision needs same-day ophthalmology assessment rather than a wait-and-see.

Question 8

When is an overactive thyroid an emergency?

Accepted Answer

Thyroid storm is the emergency, and it is genuinely rare — most people with hyperthyroidism will never come close to it, and the point of naming it is not to make ordinary symptoms sound catastrophic. It is a decompensated state, usually triggered by something else on top of untreated or under-treated hyperthyroidism — an infection, surgery, childbirth, a trauma — and it looks different in kind, not just degree: high fever, a very fast or irregular heart, agitation or confusion progressing to delirium, vomiting and diarrhoea, and signs of heart failure. That combination needs emergency care immediately, not an appointment. The other same-day situations are narrower and specific: a fever or sore throat while taking an antithyroid drug (possible agranulocytosis), jaundice while taking one (possible liver injury), and any sudden change in vision or new double vision with Graves' eye disease. A racing heart and feeling wired and anxious, on their own, are the ordinary symptoms of this condition and are a reason to be assessed — not an emergency.

Hyperthyroidism & Graves' Disease

What it is

Why it matters

What BioSignal knows about treating this

What works for Hyperthyroidism & Graves' Disease

Signal Records relevant to this condition

New to this? Read these first

How this usually unfolds

Who is at risk

How it's diagnosed

Key biomarkers

Lifestyle

Explore this condition across BioSignal

Related Foundations

Related Signal Records

Related body systems

Related conditions

Frequently asked questions